Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018)
Ironwood Pharmaceuticals (IRWD) posted Liabilities from Discontinued Operations of 15739000.0 for Q4 2018.
Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018) Analysis & Trends
Ironwood Pharmaceuticals has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 15739000.0 in Q4 2018.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 15739000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 15739000.0 (changed N/A YoY) and the FY2018 annual result came in at 15739000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 15739000.0 in Q4 2018 per IRWD's latest filing.
- Over five years, Liabilities from Discontinued Operations peaked at 15739000.0 in Q4 2018 and troughed at 15739000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Ironwood Pharmaceuticals | 668.31 Mn | 589.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 15.74 Mn |
| Dec 31, 2018 | 15.74 Mn |